Partner Bill Batchelor, associate George Zacharodimos and Pfizer senior corporate counsel Desma Polydorou discuss the transatlantic working group of leading antitrust enforcers that was recently formed to develop new principles to assess “the full range of a pharmaceutical merger’s effects on innovation.”
Transatlantic Enforcers Working Group on Pharmaceutical Mergers: Reimagining Innovation May Have Side Effects
American Bar Association's Antitrust Magazine